Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.6203
-0.0198-3.09%
Volume:62.04K
Turnover:39.24K
Market Cap:20.59M
PE:-0.25
High:0.6497
Open:0.6464
Low:0.6201
Close:0.6401
Loading ...
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 19, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 12, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 11, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2023

Major Issues Report

Form 8-K - Current report
Sep 21, 2023

Major Issues Report

Form 8-K - Current report
Sep 06, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K - Current report